Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years

Journal of Nuclear Medicine

Volumn 55, Issue 10, 2014, Pages 1578-1583

  Riedl, Christopher C ^a   Slobod, Elina ^a   Jochelson, Maxine ^a,b   Morrow, Monica ^a   Goldman, Debra A ^a   Gonen, Mithat ^a   Weber, Wolfgang A ^a,b   Ulaner, Gary A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Breast cancer; FDG; Metastases; PET; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGE; ASYMPTOMATIC DISEASE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RECTUM CANCER; RETROSPECTIVE STUDY; REVIEW; THYROID CANCER; BREAST TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; METASTASIS; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING; YOUNG ADULT;

ADULT; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAMMOGRAPHY; MULTIMODAL IMAGING; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84907515275     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.143297     Document Type: Review

References (26)

1. Theriault RL, Carlson RW, Allred C, et al. Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11:753-760.
2. Carkaci S, Macapinlac HA, Cristofanilli M, et al. Retrospective study of 18FFDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med. 2009;50:231-238.
3. Fuster D, Duch J, Paredes P, et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol. 2008;26:4746-4751.
4. Alberini JL, Lerebours F, Wartski M, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer. 2009;115:5038-5047.
5. Bernsdorf M, Berthelsen AK, Wielenga VT, et al. Preoperative PET/CT in earlystage breast cancer. Ann Oncol. 2012;23:2277-2282.
6. Groheux D, Giacchetti S, Espie M, et al. The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study. J Nucl Med. 2011;52:1526-1534.
7. Groheux D, Hindie E, Delord M, et al. Prognostic impact of 18FDG-PET-CT findings in clinical stage III and IIB breast cancer. J Natl Cancer Inst. 2012;104:1879-1887.
8. Groves AM, Shastry M, Ben-Haim S, et al. Defining the role of PET-CT in staging early breast cancer. Oncologist. 2012;17:613-619.
9. Gilardi L, Fumagalli L, Paganelli G. Preoperative PET/CT in early-stage breast cancer: is the TNM classification enough? Ann Oncol. 2013;24:852.
10. Bernsdorf M. Reply to 'preoperative PET/CT in early-stage breast cancer: is the TNM classification enough?' Ann Oncol. 2013;24:852-853.
11. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208:341-347.
12. Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E. Breast cancer in young women: clinicopathological features and biological specificity. Breast. 2003;12: 247-250.
13. Seo MJ, Lee JJ, Kim HO, et al. Detection of internal mammary lymph node metastasis with 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer. Eur J Nucl Med Mol Imaging. 2014;41:438-445.
14. Edge S, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
15. Niikura N, Costelloe CM, Madewell JE, et al. FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist. 2011;16:1111-1119.
16. Corbin KS, Hellman S,Weichselbaum RR. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013;31:1384-1390.
17. Cermik TF, Mavi A, Basu S, Alavi A. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging. 2008; 35:475-483.
18. Groheux D, Hindie E, Rubello D, et al. Should FDG PET/CT be used for the initial staging of breast cancer? Eur J Nucl Med Mol Imaging. 2009;36:1539-1542.
19. Groheux D, Moretti JL, Baillet G, et al. Effect of 18F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer. Int J Radiat Oncol Biol Phys. 2008;71:695-704.
20. Veronesi U, De Cicco C, Galimberti VE, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol. 2007;18:473-478.
21. Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 2001;19:628-633.
22. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol. 2004;22:277-285.
23. Anders CK, Fan C, Parker JS, et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol. 2011;29:e18-e20.
24. Agress H, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417-422.
25. Sebro R, Aparici CM, Pampaloni MH. Frequency and clinical implications of incidental new primary cancers detected on true whole-body 18F-FDG PET/CT studies. Nucl Med Commun. 2013;34:333-339.
26. Aukema TS, Straver ME, Peeters MJ, et al. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer. Eur J Cancer. 2010;46:3205-3210.